Table 2 Short-term and long-term outcome
Response | TAC + ZA N = 122 (49.6%) | TAC N = 124 (50.4%) | P value |
|---|---|---|---|
pCR breast and LN | |||
 Yes | 16 (13.3%) | 16 (13.2%) |  |
 No | 104 (86.7%) | 105 (86.8%) | 0.980 |
Miller and Payne | |||
 1 | 19 (15.8%) | 18 (14.8%) |  |
 2 | 35 (29.2%) | 31 (25.4%) |  |
 3 | 24 (20.0%) | 25 (20.5%) |  |
 4 | 21 (17.5%) | 25 (20.5%) |  |
 5 | 21 (17.5%) | 23 (18.9%) | 0.950 |
Recurrence | |||
 Total | 29 (23.8%) | 20 (16.1%) | 0.134 |
 Local | 5 (4.1%) | 5 (4.0%) | 0.979 |
 Regional | 7 (5.7%) | 4 (3.2%) | 0.341 |
 Distant | 27 (22.1%) | 17 (13.7%) | 0.085 |
 Second primary tumor | 5 (4.1%) | 5 (4.0%) | 0.979 |
Death | |||
 Yes | 23 (18.9%) | 11 (8.9%) |  |
 No | 99 (81.1%) | 113 (91.1%) | 0.023 |
Cause of death | |||
 Breast cancer | 22 (95.7%) | 11 (91.6%) | 0.630 |
 Other | 1 (4.3%) | 1 (8.3%) |  |